Patricia Carr, SVP, Chief Accounting Officer at Jazz Pharmaceuticals plc (JAZZ), sold 3,613 shares at $137.81 ($498K) on 2025-03-10, disclosed to the SEC on 2025-03-11.
Seasonal sale ($498k) by SVP, Chief Accounting Officer — this insider has traded JAZZ in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $138.23 | 1,333 | $184K | 37.0% |
| 2 | $137.81 | 1,140 | $157K | 31.5% |
| 3 | $137.81 | 1,140 | $157K | 31.5% |
| Total | $137.96 avg | 3,613 | $498K | 100% |
| Filing → |
| JAZZ | SELL | 2025-12-09 | $798K | — | Filing → |
| JAZZ | SELL | 2025-11-20 | $1.9M | — | Filing → |
| JAZZ | SELL | 2025-03-03 | $917K | — | Filing → |